Skip to main content
Top
Published in: Current Gastroenterology Reports 8/2017

Open Access 01-08-2017 | Neurogastroenterology and Motility Disorders of the Gastrointestinal Tract (S Rao, Section Editor)

Chicago Classification of Esophageal Motility Disorders: Lessons Learned

Authors: W. O. A. Rohof, A. J. Bredenoord

Published in: Current Gastroenterology Reports | Issue 8/2017

Login to get access

Abstract

Purpose of Review

High-resolution manometry (HRM) is increasingly performed worldwide, to study esophageal motility. The Chicago classification is subsequently applied to interpret the manometric findings and facilitate a diagnosis of esophageal motility disorders. This review will discuss new insights regarding the diagnosis and management using the Chicago classification.

Recent Findings

Recent studies have demonstrated that high-resolution manometry is superior to conventional manometry, and has a higher sensitivity to diagnose achalasia. Furthermore, the subclassification of achalasia as used in the Chicago classification has prognostic value and can be used to direct treatment. Diagnosis of esophageal spasm has been improved by using the distal latency as diagnostic criterion. Recently, criteria for minor disorders of peristalsis have been sharpened, leading to a lower rate of patients with abnormal results, thereby increasing the relevance of a diagnosis.

Summary

High-resolution manometry is now considered the gold standard for diagnosis of esophageal motility disorders. The Chicago classification provides a standardized approach for analysis and categorization of abnormalities that has led to a significant increase in our knowledge regarding the diagnosis and management of motility disorders. Further refinement of the classification will be required.
Literature
1.
go back to reference Kahrilas PJ, Bredenoord AJ, Fox M, Gyawali CP, Roman S, Smout AJ, et al. The Chicago classification of esophageal motility disorders, v3.0. Neurogastroenterol Motil. 2015;27(2):160–74.CrossRefPubMed Kahrilas PJ, Bredenoord AJ, Fox M, Gyawali CP, Roman S, Smout AJ, et al. The Chicago classification of esophageal motility disorders, v3.0. Neurogastroenterol Motil. 2015;27(2):160–74.CrossRefPubMed
2.
go back to reference Fox MR, Pandolfino JE, Sweis R, Sauter M, Abreu YAAT, Anggiansah A, et al. Inter-observer agreement for diagnostic classification of esophageal motility disorders defined in high-resolution manometry. Dis Esophagus. 2015;28(8):711–9.CrossRefPubMed Fox MR, Pandolfino JE, Sweis R, Sauter M, Abreu YAAT, Anggiansah A, et al. Inter-observer agreement for diagnostic classification of esophageal motility disorders defined in high-resolution manometry. Dis Esophagus. 2015;28(8):711–9.CrossRefPubMed
3.
go back to reference Carlson DA, Ravi K, Kahrilas PJ, Gyawali CP, Bredenoord AJ, Castell DO, et al. Diagnosis of esophageal motility disorders: esophageal pressure topography vs. conventional line tracing. Am J Gastroenterol. 2015;110(7):967–77. quiz 78CrossRefPubMedPubMedCentral Carlson DA, Ravi K, Kahrilas PJ, Gyawali CP, Bredenoord AJ, Castell DO, et al. Diagnosis of esophageal motility disorders: esophageal pressure topography vs. conventional line tracing. Am J Gastroenterol. 2015;110(7):967–77. quiz 78CrossRefPubMedPubMedCentral
4.
go back to reference Soudagar AS, Sayuk GS, Gyawali CP. Learners favour high resolution oesophageal manometry with better diagnostic accuracy over conventional line tracings. Gut. 2012;61(6):798–803.CrossRefPubMed Soudagar AS, Sayuk GS, Gyawali CP. Learners favour high resolution oesophageal manometry with better diagnostic accuracy over conventional line tracings. Gut. 2012;61(6):798–803.CrossRefPubMed
5.
go back to reference •• Roman S, Huot L, Zerbib F, Bruley des Varannes S, Gourcerol G, Coffin B, et al. High-resolution manometry improves the diagnosis of esophageal motility disorders in patients with dysphagia: a randomized multicenter study. Am J Gastroenterol. 2016;111(3):372–80. This study demonstrates that high resolution manometry significantly increases the rate of relevant diagnoses compared to conventional manometry in patients with dysphagia. CrossRefPubMed •• Roman S, Huot L, Zerbib F, Bruley des Varannes S, Gourcerol G, Coffin B, et al. High-resolution manometry improves the diagnosis of esophageal motility disorders in patients with dysphagia: a randomized multicenter study. Am J Gastroenterol. 2016;111(3):372–80. This study demonstrates that high resolution manometry significantly increases the rate of relevant diagnoses compared to conventional manometry in patients with dysphagia. CrossRefPubMed
7.
go back to reference Pandolfino JE, Kwiatek MA, Nealis T, Bulsiewicz W, Post J, Kahrilas PJ. Achalasia: a new clinically relevant classification by high-resolution manometry. Gastroenterology. 2008;135(5):1526–33.CrossRefPubMedPubMedCentral Pandolfino JE, Kwiatek MA, Nealis T, Bulsiewicz W, Post J, Kahrilas PJ. Achalasia: a new clinically relevant classification by high-resolution manometry. Gastroenterology. 2008;135(5):1526–33.CrossRefPubMedPubMedCentral
8.
go back to reference Rohof WO, Salvador R, Annese V, Bruley des Varannes S, Chaussade S, Costantini M, et al. Outcomes of treatment for achalasia depend on manometric subtype. Gastroenterology. 2013;144(4):718–25. quiz e13-4CrossRefPubMed Rohof WO, Salvador R, Annese V, Bruley des Varannes S, Chaussade S, Costantini M, et al. Outcomes of treatment for achalasia depend on manometric subtype. Gastroenterology. 2013;144(4):718–25. quiz e13-4CrossRefPubMed
9.
go back to reference Salvador R, Costantini M, Zaninotto G, Morbin T, Rizzetto C, Zanatta L, et al. The preoperative manometric pattern predicts the outcome of surgical treatment for esophageal achalasia. J Gastrointest Surg. 2010;14(11):1635–45.CrossRefPubMed Salvador R, Costantini M, Zaninotto G, Morbin T, Rizzetto C, Zanatta L, et al. The preoperative manometric pattern predicts the outcome of surgical treatment for esophageal achalasia. J Gastrointest Surg. 2010;14(11):1635–45.CrossRefPubMed
10.
go back to reference Zhang W, Linghu EQ. Peroral endoscopic myotomy for type III achalasia of Chicago classification: outcomes with a minimum follow-up of 24 months. J Gastrointest Surg. 2017. Zhang W, Linghu EQ. Peroral endoscopic myotomy for type III achalasia of Chicago classification: outcomes with a minimum follow-up of 24 months. J Gastrointest Surg. 2017.
11.
go back to reference van Hoeij FB, Smout AJ, Bredenoord AJ. Characterization of idiopathic esophagogastric junction outflow obstruction. Neurogastroenterol Motil. 2015;27(9):1310–6.CrossRefPubMed van Hoeij FB, Smout AJ, Bredenoord AJ. Characterization of idiopathic esophagogastric junction outflow obstruction. Neurogastroenterol Motil. 2015;27(9):1310–6.CrossRefPubMed
12.
go back to reference Perez-Fernandez MT, Santander C, Marinero A, Burgos-Santamaria D, Chavarria-Herbozo C. Characterization and follow-up of esophagogastric junction outflow obstruction detected by high resolution manometry. Neurogastroenterol Motil. 2016;28(1):116–26.CrossRefPubMed Perez-Fernandez MT, Santander C, Marinero A, Burgos-Santamaria D, Chavarria-Herbozo C. Characterization and follow-up of esophagogastric junction outflow obstruction detected by high resolution manometry. Neurogastroenterol Motil. 2016;28(1):116–26.CrossRefPubMed
13.
go back to reference Porter RF, Gyawali CP. Botulinum toxin injection in dysphagia syndromes with preserved esophageal peristalsis and incomplete lower esophageal sphincter relaxation. Neurogastroenterol Motil. 2011;23(2):139–44. e27-8CrossRefPubMed Porter RF, Gyawali CP. Botulinum toxin injection in dysphagia syndromes with preserved esophageal peristalsis and incomplete lower esophageal sphincter relaxation. Neurogastroenterol Motil. 2011;23(2):139–44. e27-8CrossRefPubMed
15.
go back to reference Pandolfino JE, Roman S, Carlson D, Luger D, Bidari K, Boris L, et al. Distal esophageal spasm in high-resolution esophageal pressure topography: defining clinical phenotypes. Gastroenterology. 2011;141(2):469–75.CrossRefPubMedPubMedCentral Pandolfino JE, Roman S, Carlson D, Luger D, Bidari K, Boris L, et al. Distal esophageal spasm in high-resolution esophageal pressure topography: defining clinical phenotypes. Gastroenterology. 2011;141(2):469–75.CrossRefPubMedPubMedCentral
16.
go back to reference De Schepper HU, Ponds FA, Oors JM, Smout AJ, Bredenoord AJ. Distal esophageal spasm and the Chicago classification: is timing everything? Neurogastroenterol Motil. 2016;28(2):260–5.CrossRefPubMed De Schepper HU, Ponds FA, Oors JM, Smout AJ, Bredenoord AJ. Distal esophageal spasm and the Chicago classification: is timing everything? Neurogastroenterol Motil. 2016;28(2):260–5.CrossRefPubMed
17.
go back to reference Cattau EL Jr, Castell DO, Johnson DA, Spurling TJ, Hirszel R, Chobanian SJ, et al. Diltiazem therapy for symptoms associated with nutcracker esophagus. Am J Gastroenterol. 1991;86(3):272–6.PubMed Cattau EL Jr, Castell DO, Johnson DA, Spurling TJ, Hirszel R, Chobanian SJ, et al. Diltiazem therapy for symptoms associated with nutcracker esophagus. Am J Gastroenterol. 1991;86(3):272–6.PubMed
18.
go back to reference Orlando RC, Bozymski EM. Clinical and manometric effects of nitroglycerin in diffuse esophageal spasm. N Engl J Med. 1973;289(1):23–5.CrossRefPubMed Orlando RC, Bozymski EM. Clinical and manometric effects of nitroglycerin in diffuse esophageal spasm. N Engl J Med. 1973;289(1):23–5.CrossRefPubMed
19.
go back to reference • Vanuytsel T, Bisschops R, Farre R, Pauwels A, Holvoet L, Arts J, et al. Botulinum toxin reduces dysphagia in patients with nonachalasia primary esophageal motility disorders. Clin Gastroenterol Hepatol. 2013;11(9):1115–21. e2. This small sham-controlled study demonstrates that botulinum toxin significantly reduces dysphagia in patients with hypertensive motility disorders. CrossRefPubMed • Vanuytsel T, Bisschops R, Farre R, Pauwels A, Holvoet L, Arts J, et al. Botulinum toxin reduces dysphagia in patients with nonachalasia primary esophageal motility disorders. Clin Gastroenterol Hepatol. 2013;11(9):1115–21. e2. This small sham-controlled study demonstrates that botulinum toxin significantly reduces dysphagia in patients with hypertensive motility disorders. CrossRefPubMed
20.
go back to reference Khan MA, Kumbhari V, Ngamruengphong S, Ismail A, Chen YI, Chavez YH, et al. Is POEM the answer for management of spastic esophageal disorders? A systematic review and meta-analysis. Dig Dis Sci. 2017;62(1):35–44.CrossRefPubMed Khan MA, Kumbhari V, Ngamruengphong S, Ismail A, Chen YI, Chavez YH, et al. Is POEM the answer for management of spastic esophageal disorders? A systematic review and meta-analysis. Dig Dis Sci. 2017;62(1):35–44.CrossRefPubMed
21.
go back to reference Roman S, Tutuian R. Esophageal hypertensive peristaltic disorders. Neurogastroenterol Motil. 2012;24(Suppl 1):32–9.CrossRefPubMed Roman S, Tutuian R. Esophageal hypertensive peristaltic disorders. Neurogastroenterol Motil. 2012;24(Suppl 1):32–9.CrossRefPubMed
22.
go back to reference Roman S, Pandolfino JE, Chen J, Boris L, Luger D, Kahrilas PJ. Phenotypes and clinical context of hypercontractility in high-resolution esophageal pressure topography (EPT). Am J Gastroenterol. 2012;107(1):37–45.CrossRefPubMed Roman S, Pandolfino JE, Chen J, Boris L, Luger D, Kahrilas PJ. Phenotypes and clinical context of hypercontractility in high-resolution esophageal pressure topography (EPT). Am J Gastroenterol. 2012;107(1):37–45.CrossRefPubMed
23.
go back to reference Herregods TV, Smout AJ, Ooi JL, Sifrim D, Bredenoord AJ. Jackhammer esophagus: observations on a European cohort. Neurogastroenterol Motil. 2017;29(4) Herregods TV, Smout AJ, Ooi JL, Sifrim D, Bredenoord AJ. Jackhammer esophagus: observations on a European cohort. Neurogastroenterol Motil. 2017;29(4)
24.
go back to reference Marjoux S, Brochard C, Roman S, Gincul R, Pagenault M, Ponchon T, et al. Botulinum toxin injection for hypercontractile or spastic esophageal motility disorders: may high-resolution manometry help to select cases? Dis Esophagus. 2015;28(8):735–41.CrossRefPubMed Marjoux S, Brochard C, Roman S, Gincul R, Pagenault M, Ponchon T, et al. Botulinum toxin injection for hypercontractile or spastic esophageal motility disorders: may high-resolution manometry help to select cases? Dis Esophagus. 2015;28(8):735–41.CrossRefPubMed
25.
go back to reference Crowell MD, Umar SB, Griffing WL, DiBaise JK, Lacy BE, Vela MF. Esophageal motor abnormalities in patients with scleroderma: heterogeneity, risk factors, and effects on quality of life. Clin Gastroenterol Hepatol. 2017;15(2):207–13. e1CrossRefPubMed Crowell MD, Umar SB, Griffing WL, DiBaise JK, Lacy BE, Vela MF. Esophageal motor abnormalities in patients with scleroderma: heterogeneity, risk factors, and effects on quality of life. Clin Gastroenterol Hepatol. 2017;15(2):207–13. e1CrossRefPubMed
26.
go back to reference Carlson DA, Crowell MD, Kimmel JN, Patel A, Gyawali CP, Hinchcliff M, et al. Loss of peristaltic reserve, determined by multiple rapid swallows, is the most frequent esophageal motility abnormality in patients with systemic sclerosis. Clin Gastroenterol Hepatol. 2016;14(10):1502–6.CrossRefPubMed Carlson DA, Crowell MD, Kimmel JN, Patel A, Gyawali CP, Hinchcliff M, et al. Loss of peristaltic reserve, determined by multiple rapid swallows, is the most frequent esophageal motility abnormality in patients with systemic sclerosis. Clin Gastroenterol Hepatol. 2016;14(10):1502–6.CrossRefPubMed
27.
go back to reference • Ravi K, Friesen L, Issaka R, Kahrilas PJ, Pandolfino JE. Long-term outcomes of patients with normal or minor motor function abnormalities detected by high-resolution esophageal manometry. Clin Gastroenterol Hepatol. 2015;13(8):1416–23. This study demonstrated that symptoms in most patients with minor motility disorders resolve during a longer follow up period. CrossRefPubMedPubMedCentral • Ravi K, Friesen L, Issaka R, Kahrilas PJ, Pandolfino JE. Long-term outcomes of patients with normal or minor motor function abnormalities detected by high-resolution esophageal manometry. Clin Gastroenterol Hepatol. 2015;13(8):1416–23. This study demonstrated that symptoms in most patients with minor motility disorders resolve during a longer follow up period. CrossRefPubMedPubMedCentral
28.
go back to reference Monrroy H, Cisternas D, Bilder C, Ditaranto A, Remes-Troche J, Meixueiro A, et al. The Chicago classification 3.0 results in more normal findings and fewer hypotensive findings with no difference in other diagnoses. Am J Gastroenterol. 2017;112(4):606–12.CrossRefPubMed Monrroy H, Cisternas D, Bilder C, Ditaranto A, Remes-Troche J, Meixueiro A, et al. The Chicago classification 3.0 results in more normal findings and fewer hypotensive findings with no difference in other diagnoses. Am J Gastroenterol. 2017;112(4):606–12.CrossRefPubMed
Metadata
Title
Chicago Classification of Esophageal Motility Disorders: Lessons Learned
Authors
W. O. A. Rohof
A. J. Bredenoord
Publication date
01-08-2017
Publisher
Springer US
Published in
Current Gastroenterology Reports / Issue 8/2017
Print ISSN: 1522-8037
Electronic ISSN: 1534-312X
DOI
https://doi.org/10.1007/s11894-017-0576-7

Other articles of this Issue 8/2017

Current Gastroenterology Reports 8/2017 Go to the issue

Inflammatory Bowel Disease (S Hanauer, Section Editor)

Quality Improvement Initiatives in Inflammatory Bowel Disease

Stomach and Duodenum (J Pisegna and J Benhammou, Section Editors)

The Gastric and Intestinal Microbiome: Role of Proton Pump Inhibitors

Pediatric Gastroenterology (S Orenstein, Section Editor)

Clostridium Difficile, Colitis, and Colonoscopy: Pediatric Perspective

Esophagus (J Clarke and N Ahuja, Section Editors)

Hiatus Hernia as a Cause of Dysphagia

Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.